期刊文献+

乳腺癌干细胞调控及靶向治疗研究进展 被引量:1

Progress on Regulation and Targeted Therapy of Breast Cancer Stem Cells
原文传递
导出
摘要 乳腺癌干细胞是乳腺肿瘤内具有自我更新能力以及多向分化潜能的细胞,乳腺癌的发生﹑发展、转移﹑复发与干细胞的高致瘤性、高侵袭转移性、治疗抵抗能力密切相关。深入研究乳腺癌干细胞相关细胞因子及微环境因素的调控对乳腺癌的临床靶向治疗具有重要指导意义。该文就近年来乳腺癌干细胞调控相关信号转导通路、转录因子、表观遗传调控因子以及微环境因素进行综述,探讨乳腺癌干细胞及其相关信号因子作为乳腺癌治疗靶点的潜在价值,为临床靶向治疗乳腺癌提供新方向。 Breast cancer stem cells are cells with self-renewal capabilities and the potential for multidirec-tional differentiation within breast tumors.The occurrence,development,metastasis,and recurrence of breast can-cer are closely associated with the high tumorigenicity,high invasive metastatic ability,and treatment resistance of stem cells.In-depth research on the regulation of breast cancer stem cells-related cytokines and microenvironmental factors is of significant guiding importance for clinical targeted therapy of breast cancer.This article reviews recent advances in the regulation of breast cancer stem cells,including signaling pathways,transcription factors,epigen-etic regulatory factors,and microenvironmental factors.It explores the potential value of breast cancer stem cells and their associated signaling factors as therapeutic targets for breast cancer,providing new directions for clinical targeted therapy of breast cancer.
作者 潘琳 伍家发 郭赛楠 牛明福 PAN Lin;WU Jiafa;GUO Sainan;NIU Mingfu(College of Food and Bioengineering,Henan University of Science and Technology,National Experimental Teaching Demonstration Center for Food Processing and Safety,Luoyang 471000,China)
出处 《中国细胞生物学学报》 CAS CSCD 2024年第3期568-575,共8页 Chinese Journal of Cell Biology
基金 河南省自然科学基金(批准号:162300410099)资助的课题。
关键词 乳腺癌干细胞 乳腺癌 信号通路 靶向治疗 breast cancer stem cells breast cancer signaling pathways targeted therapy
  • 相关文献

参考文献3

二级参考文献83

  • 1Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 1994, 17,367(6464): 645-648.
  • 2Al Hajj M, Wicha M S, Benito-Hemandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 2003, 100(11): 3983-3988.
  • 3Reya T, Morrison S J, Clarke M F, et al. Stem ceils, cancer, and cancer stem cells. Nature, 2001, 414(6859): 105-111.
  • 4Singh S K, Clarke I D, Teraski M, et ol. Identification of a cancer stem cell in human brain tumors. Cancer Res, 2003, 63(18): 5821-5828.
  • 5Pardal R, Clarke M F, Morrison S J. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer, 2003, 3(12): 895-902.
  • 6Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proe Natl Acad Sci USA, 2004, 101(3): 781-786.
  • 7Ginestier C, Hut M H, Charafe-Jauffret E, et al. ALDHI is a marker of normal and malignant human mammary stem cells. Cell Stem Cell, 2007, 1(5): 555-567.
  • 8Clevers H. Wnt/beta-catenin signaling in development and disease.Cell, 2006, 127(3): 469-480.
  • 9Gaston-Massuet C, Andoniadou C L, Signora M, et al. Increased wingless(Wnt)signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci USA, 2011,108(28): 11482-11487.
  • 10Korine k V, Barker N, Morin P J, et al.Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science, 1997, 275(5307): 1784-1787.

共引文献10

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部